MedPath

The Effect of Aerobic Endurance Training in Patients With Drug Addiction

Not Applicable
Completed
Conditions
Substance-Related Disorders
Registration Number
NCT02017821
Lead Sponsor
Norwegian University of Science and Technology
Brief Summary

Physical health does not have a high priority in today's treatment of patients with substance use disorder (SUD) patients have a poor physical health not only due to injuries related to the substance abuse, but also because of the lifestyle that addiction causes. There are today few studies that provide information about SUD patients' physical health. One of the project's aims is to document the physical health of SUD patients in treatment, using objective measures. After completion of various physical tests, an 8 week period of high intensity aerobic training intervention will follow. It will be investigated if the SUD patients are able to engage and participate throughout the whole training intervention, to what degree the participants improve their physical health and the effect of physical health improvement on substance abuse treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria
  • substance use disorder diagnosed ICD10
  • written informed consent
  • "residential treatment"
Exclusion Criteria
  • not been using drugs the last six months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
change in maximal oxygen consumption (VO2 max)from baseline to 8 weeks

Directly measurement of maximal oxygen consumption. Measurement of work efficiency and lactate measurements. Insomnia Severity Index and Hospital Anxiety and Depression scale is used to measure mental health.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Trondheims Klinikken, St Olavs Hospital

🇳🇴

Trondheim, Norway

Trondheims Klinikken, St Olavs Hospital
🇳🇴Trondheim, Norway

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.